[Intraocular correction of aphakia in patients after kidney transplantation].

Abstract

It was for the first time in the ophthalmologic practice that a possibility was demonstrated to ensure relatively high and stable functional results, in a significant number of patients with transplanted kidney (TK), related with different-type cataract extraction and with implantation of a variety of PMMA IOLs, i.e. model of B.A. Alexeev, "Storz" company models made from domestic and foreign-made PMMA and domestic-silicone models (P = 70). It was established that IOL implantation in patients with TK is possible in all cases provided the kidney transplant is compensated for and there are no foci of acute or chronic inflammation in the body. A minimal trauma caused by surgery and the suggested scheme of postoperative management (intramuscular injections of antibiotics and supplementary administration of solutions of poludan, naclof, catachrom and actovegin-gel made alongside with routine instillations) cuts the risk of infectious-and-inflammatory as well as of degenerative-and-dystrophic complications in patients with TK receiving the suppressor therapy. Clinical examinations denoted that the intraocular aphakia correction in patients with TK is a method of choice accelerating the medical and social rehabilitation in the discussed patients' category provided the therapeutic-and-diagnostic as well as preventive measures, as required by their status, are being taken.

• Authors: V E Bocharov, M N Ivanov, P I Gantsovskiĭ
• Journal: Vestnik oftalmologii (Vestn Oftalmol) 2004 Jul-Aug Vol. 120 Issue 4 Pg. 21-4 ISSN: 0042-465X [Print] Russia (Federation)
• Vernacular Title: Intraokuliarnaia korrektsiia afakii u bol'nykh, perenesshikh transplantatsiiu pochki.
• PMID: 15384842 (Publication Type: English Abstract, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Antioxidants
• Interferon Inducers
• Polyribonucleotides
• poludan
• Heme
• Actovegin

Topics

• Adult
• Age Factors
• Aged
• Anti-Bacterial Agents (administration & dosage, therapeutic use)
• Antioxidants (administration & dosage, therapeutic use)
• Cataract Extraction
• Drug Therapy, Combination
• Heme (administration & dosage, analogs & derivatives, therapeutic use)
• Humans
• Injections, Intramuscular
• Interferon Inducers (administration & dosage, therapeutic use)
• Kidney Transplantation
• Lens Implantation, Intraocular
• Middle Aged
• Polyribonucleotides (administration & dosage, therapeutic use)
• Postoperative Care